| Literature DB >> 32515742 |
Maarten A van Egmond1,2,3, Raoul H H Engelbert1,2, Jean H G Klinkenbijl4,5, Mark I van Berge Henegouwen6, Marike van der Schaaf1,2.
Abstract
BACKGROUND: Improvement of functional status with physiotherapy is an important goal for patients with postoperative complications and an increased length of hospital stay (LoS) after esophagectomy. Supervised physiotherapy with telerehabilitation instead of conventional face-to-face care could be an alternative to treat these patients in their home environment after hospital discharge (T0), but its feasibility has not yet been investigated in detail.Entities:
Keywords: esophageal neoplasms; physical therapy modalities; surgical oncology; telemedicine; telerehabilitation
Mesh:
Year: 2020 PMID: 32515742 PMCID: PMC7312239 DOI: 10.2196/16056
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Goal-oriented exercise program created by the physiotherapist, accessible by tablet, mobile phone, or computer (Used with permission from Physitrack).
Characteristics of the entire study population.
| Patient characteristics | Study population (N=22) | ||
| Gender (male), n (%) | 17 (77) | ||
|
| |||
|
| Ib | 5 (22) | |
|
| IIc | 10 (45) | |
|
| IIId | 7 (31) | |
| Age (years), mean (SD) | 64.6 (6.7) | ||
| BMIe, mean (SD) | 26.5 (4.4) | ||
|
| |||
|
| Cardiovascular | 7 (31) | |
|
| COPDf | 0 (0) | |
|
| DM IIg | 2 (9) | |
|
| Cigarette smoking | 2 (9) | |
|
| |||
|
| FVCh | 116.1 (18.7) | |
|
| FEV1i | 109.0 (19.3) | |
|
| IVCj | 109.2 (30.1) | |
|
| |||
|
| Transhiatal open | 0 (0) | |
|
| Transhiatal minimally invasive | 1 (5) | |
|
| Transthoracal open | 0 (0) | |
|
| Transthoracal minimally invasive | 20 (91) | |
|
| Esophageal resection with colon interposition | 1 (5) | |
|
| |||
|
| No complications | 2 (9) | |
|
| Grade 1 | 2 (9) | |
|
| Grade 2 | 4 (18) | |
|
| Grade 3a | 3 (14) | |
|
| Grade 3b | 4 (18) | |
|
| Grade 4a | 7 (32) | |
|
| Grade 4b | 0 (0) | |
|
| Grade 5 | 0 (0) | |
aASA: American Society of Anesthesiologists.
bI: healthy person.
cII: mild systemic disease.
dIII: severe systemic disease.
eBMI: body mass index is calculated as weight in kilograms divided by height in meters squared.
fCOPD: chronic obstructive pulmonary disease.
gDM II: diabetes mellitus type 2.
hFVC: functional vital capacity.
iFEV1: forced expiratory volume in the first second of expiration.
jIVC: inspiratory vital capacity.
Patient characteristics of the intervention group matched with a historical comparison group.
| Patient characteristics | Intervention (n=15) | Matched controls (n=30) | |
| Gender (male), n (%) | 11 (73) | 22 (73) | |
|
| |||
|
| Ib | 3 (20) | 5 (16) |
|
| IIc | 8 (53) | 15 (50) |
|
| IIId | 4 (26) | 10 (33) |
| Age (years), mean (SD) | 62.8 (6.9) | 60.3 (7) | |
| BMIe, mean (SD) | 26.1 (3.5) | 25.2 (4) | |
|
| |||
|
| Cardiovascular | 6 (40) | 5 (16) |
|
| COPDf | 0 (0) | 3 (10) |
|
| DM IIg | 1 (7) | 1 (3) |
|
| Cigarette smoking | 1 (7) | 7 (23) |
|
| |||
|
| FVCh | 115.0 (20.1) | 116.3 (16.2) |
|
| FEV1i | 105.4 (20.1) | 110.2 (20.7) |
|
| IVCj | 114.1 (21.9) | 112.0 (16.7) |
|
| |||
|
| Transhiatal open | 0 (0) | 0 (0) |
|
| Transhiatal minimally invasive | 0 (0) | 2 (7) |
|
| Transthoracal open | 0 (0) | 1 (3) |
|
| Transthoracal minimally invasive | 14 (93) | 27 (90) |
|
| Esophageal resection with colon interposition | 1 (7) | 0 (0) |
|
| |||
|
| No complications | 2 (13) | 11 (37) |
|
| Grade 1 | 2 (13) | 4 (13) |
|
| Grade 2 | 2 (13) | 7 (23) |
|
| Grade 3a | 3 (20) | 4 (13) |
|
| Grade 3b | 2 (13) | 1 (3) |
|
| Grade 4a | 4 (27) | 2 (7) |
|
| Grade 4b | 0 (0) | 1 (3) |
|
| Grade 5 | 0 (0) | 0 (0) |
aASA: American Society of Anesthesiologists.
bI: healthy person.
cII: mild systemic disease.
dIII: severe systemic disease.
eBMI: body mass index is calculated as weight in kilograms divided by height in meters squared.
fCOPD: chronic obstructive pulmonary disease.
gDM II: diabetes mellitus type 2.
hFVC: functional vital capacity.
iFEV1: forced expiratory volume in the first second of expiration.
jIVC: inspiratory vital capacity.
Functional status capacity outcome measures at hospital discharge (T0). Beta values represent the differences in functional status between the historical control group and the intervention group at T0.
| Functional status outcome | Intervention | Control | Beta | 95% CI | |
| RHGSa (percent predicted), mean (SD) | 92.4 (19.7) | 107.9 (23.2) | −15.5 | −31.9 to 0.79 | .04b |
| LHGSc (percent predicted), mean (SD) | 97.1 (20.8) | 106.2 (22.4) | −11.9 | −26.6 to 2.9 | .11b |
| 30CSTd (percent predicted), mean (SD) | 50.8 (31.6) | 89.0 (34.4) | −33.2 | −53.8 to −12.7 | .003b |
| 2MWTe (meters), mean (SD) | 117.4 (50.6) | 154.4 (32.3) | −22.6 | −42.7 to −2.5 | .03b |
aRHGS: right-hand grip strength.
bP≤.05 is considered significant.
cLHGS: left-hand grip strength.
d30CST: 30-second chair stand test.
e2MWT: 2-min walk test.
Within-group differences between hospital discharge (T0) and 3 months post operation (T2) and between-group differences at T2 in measures of functional status. Within-group differences represent the differences in functional status between T0 and T2. Beta values represent the differences in functional status between the historical control group and the intervention group at T2.
| Functional status outcome | Within-group differences (T0-T2)a,b | Between-group differences at T2 | |||||
|
| Intervention (n=15) | Historical control (n=30) | Beta | ||||
|
| Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | ||||
| LHGSc | 10.4 (0.1 to 20.8) | .048d | −4.1 (−8.7 to 0.5) | .08 | 0.8 (14.2 to −12.7) | .91 | |
| RHGSe | 12.3 (0.9 to 23.7) | .04d | −3.2 (−8.9 to 2.4) | .25 | −1.0 (−15.3 to 13.3) | .89 | |
| MIPf,g | —h | — | — | — | 13.7 (−14.0 to 41.4) | .32 | |
| 30CSTi | 69.7 (51.6 to 87.8) | <.001d | 29.8 (18.7 to 40.9) | <.001d | 5.9 (−15.3 to 27.0) | .58 | |
| 2MWTj | 82.4 (53.4 to 111.3) | .001d | 41.2 (27.3 to 55.1) | <.001d | 16.8 (−7.6 to 41.2) | .17 | |
| ADLg,k | — | — | — | — | −444.3 (−1417.0 to 528.3) | .36 | |
| Fatigueg | — | — | — | — | −3.6 (−16.0 to 8.8) | .55 | |
| HRQLl | — | — | — | — | 3.5 (−9.0 to 16.11) | .57 | |
aT0: hospital discharge.
bT2: 3 months post operation.
cLHGS: left-hand grip strength.
dP<.05 is considered significant.
eRHGS: right-hand grip strength.
fMIP: maximal inspiratory pressure.
gThese measurements were not performed at T0 and therefore were excluded from this analysis.
hMissing data.
i30CST: 30-second chair stand test.
j2MWT: 2-min walk test.
kADL: activities of daily life.
lHRQL: health-related quality of life.
Mean differences in functional status outcomes between hospital discharge and 6 weeks post operation (T1) and between T1 and 3 months post operation in the intervention group (n=15).
| Measurements | ΔaT0-T1b,c (95% CI) | ΔT1-T2d (95% CI) | ||
| RHGSe | 7.4 (−5.1 to 19.8) | .22 | 5.1 (−1.5 to 11.6) | .12 |
| LHGSf | 9.6 (−0.6 to 19.8) | .06 | 1.0 (−5.0 to 6.9) | .74 |
| MIPg,h | —i | — | 9.6 (−1.1 to 20.3) | .07 |
| 30CSTj | 53.0 (38.5 to 67.5) | <.001k | 19.0 (10.2 to 27.9) | .001k |
| 2 MWT (m)l | 51.0 (21.9 to 80.2) | .002k | 30.3 (15.5 to 445.0) | .001k |
| MFIm fatigue | −10.2 (−16.8 to −3.6) | .007k | −16.8 (−24.6 to −9.0) | .001k |
| EORTC QLQ C30n, (score) | 25.6 (14.6 to 36.5) | <.001k | 14.6 (6.4 to 22.8) | .002k |
| LAPAQo (kcal/day) | −514.7 (−866.7 to 160.7) | .008k | 173.6 (9.5 to 337.7) | .04k |
aΔ: mean difference.
bT0: hospital discharge.
cT1: 6 weeks post operation.
dT2: 3 months post operation.
eRHGS: right-hand grip strength.
fLHGS: left-hand grip strength.
gMIP: maximal inspiratory pressure.
hThese measurements were not performed at T0 and therefore were excluded from this analysis.
iMissing data.
j30CST: 30-second chair stand test.
kP<.05 is considered significant.
l2MWT: 2-min walk test.
mMFI: Multidimensional Fatigue Inventory; scores range from 20 to 100, with a higher score representing more fatigue and reduced activity/motivation.
nEORTC QLQ C30: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30; scores range from 0 to 100, with high scores indicating a better quality of life.
oLAPAQ: Longitudinal Ageing Study Amsterdam physical activity questionnaire; total amount of activities in kilocalories per day.